Stock Analysis

Investors are selling off Quipt Home Medical (TSE:QIPT), lack of profits no doubt contribute to shareholders three-year loss

While not a mind-blowing move, it is good to see that the Quipt Home Medical Corp. (TSE:QIPT) share price has gained 11% in the last three months. But that doesn't change the fact that the returns over the last three years have been less than pleasing. After all, the share price is down 40% in the last three years, significantly under-performing the market.

Since Quipt Home Medical has shed CA$22m from its value in the past 7 days, let's see if the longer term decline has been driven by the business' economics.

View our latest analysis for Quipt Home Medical

Because Quipt Home Medical made a loss in the last twelve months, we think the market is probably more focussed on revenue and revenue growth, at least for now. When a company doesn't make profits, we'd generally hope to see good revenue growth. That's because fast revenue growth can be easily extrapolated to forecast profits, often of considerable size.

In the last three years, Quipt Home Medical saw its revenue grow by 32% per year, compound. That's well above most other pre-profit companies. While its revenue increased, the share price dropped at a rate of 12% per year. That seems like an unlucky result for holders. It seems likely that actual growth fell short of shareholders' expectations. Before considering a purchase, investors should consider how quickly expenses are growing, relative to revenue.

You can see how earnings and revenue have changed over time in the image below (click on the chart to see the exact values).

earnings-and-revenue-growth
TSX:QIPT Earnings and Revenue Growth February 21st 2025

We consider it positive that insiders have made significant purchases in the last year. Even so, future earnings will be far more important to whether current shareholders make money. If you are thinking of buying or selling Quipt Home Medical stock, you should check out this free report showing analyst profit forecasts.

Advertisement

A Different Perspective

Investors in Quipt Home Medical had a tough year, with a total loss of 39%, against a market gain of about 20%. Even the share prices of good stocks drop sometimes, but we want to see improvements in the fundamental metrics of a business, before getting too interested. On the bright side, long term shareholders have made money, with a gain of 4% per year over half a decade. If the fundamental data continues to indicate long term sustainable growth, the current sell-off could be an opportunity worth considering. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. To that end, you should be aware of the 1 warning sign we've spotted with Quipt Home Medical .

If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: most of them are flying under the radar).

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Canadian exchanges.

Valuation is complex, but we're here to simplify it.

Discover if Quipt Home Medical might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About TSX:QIPT

Quipt Home Medical

Through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States.

Undervalued with mediocre balance sheet.

Advertisement

Weekly Picks

FA
7202 logo
FAI on Arabian Internet and Communication Services ·

Solutions by stc: 34% Upside in Saudi's Digital Transformation Leader

Fair Value:ر.س342.2335.5% undervalued
10 users have followed this narrative
1 users have commented on this narrative
4 users have liked this narrative
RO
RobertoAllende
NVDA logo
RobertoAllende on NVIDIA ·

The AI Infrastructure Giant Grows Into Its Valuation

Fair Value:US$345.0747.9% undervalued
28 users have followed this narrative
28 users have commented on this narrative
21 users have liked this narrative

Updated Narratives

TA
Talos
NVDA logo
Talos on NVIDIA ·

Not a Bubble, But the "Industrial Revolution 4.0" Engine

Fair Value:US$294.9239.0% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
TA
Talos
AMD logo
Talos on Advanced Micro Devices ·

The "David vs. Goliath" AI Trade – Why Second Place is Worth Billions

Fair Value:US$416.4647.2% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
TA
Talos
PYPL logo
Talos on PayPal Holdings ·

The "Sleeping Giant" Wakes Up – Efficiency & Monetization

Fair Value:US$174.9264.2% undervalued
7 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

TH
TheWallstreetKing
MVIS logo
TheWallstreetKing on MicroVision ·

MicroVision will explode future revenue by 380.37% with a vision towards success

Fair Value:US$6098.6% undervalued
111 users have followed this narrative
11 users have commented on this narrative
22 users have liked this narrative
AN
AnalystConsensusTarget
NVDA logo
AnalystConsensusTarget on NVIDIA ·

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

Fair Value:US$250.3928.1% undervalued
945 users have followed this narrative
6 users have commented on this narrative
24 users have liked this narrative
OS
oscargarcia
GOOGL logo
oscargarcia on Alphabet ·

The company that turned a verb into a global necessity and basically runs the modern internet, digital ads, smartphones, maps, and AI.

Fair Value:US$3407.4% undervalued
147 users have followed this narrative
6 users have commented on this narrative
18 users have liked this narrative